结核性视网膜血管炎合作眼结核研究(COTS)-1:251例患者的多国回顾性分析
多国多中心回顾性研究纳入2004年1月至2014年12月间251例结核性视网膜血管炎患者,随访至少1年。接受抗结核治疗者治疗失败率为13.6%(31/228),未接受者为21.7%(5/23),差异无统计学意义(P=0.29)。作者结论为抗结核治疗无显著疗效,但因未治疗患者极少且随访仅1年,无法作出确定性结论。
要点
- 251例结核性视网膜血管炎患者以男性(66.5%,167/251)和亚洲裔(70.7%,174/246)为主。
- 接受抗结核治疗者治疗失败率13.6%(31/228) vs 未接受者21.7%(5/23),差异无统计学意义(P=0.29)。
- 闭塞型视网膜血管炎患者接受抗结核治疗后失败较少,但生存分析未达统计学显著(P=0.09)。
核心结论
- 在这项结核性视网膜血管炎多国研究中,抗结核治疗无显著治疗效应。
- 由于未接受抗结核治疗的患者极少,无法就抗结核治疗的作用作出确定性结论。
- 因本研究为回顾性研究且随访仅限1年,抗结核治疗的效应在随访期间可能被高估或低估。
研究设计与样本
- 多中心回顾性研究,纳入2004年1月至2014年12月间诊断为结核性视网膜血管炎且随访至少1年的患者。
- 共纳入251例结核性视网膜血管炎患者,平均年龄38.9±14.4岁(范围9-86岁)。
主要发现
- 患者以男性为主(167/251,66.5%),亚洲裔174/246(70.7%),地理来源137/251(54.6%)。
- 多数患者具有闭塞型视网膜血管炎特征(113/185,61.1%),但白种人除外(11例,28.2%)。
- 接受抗结核治疗者治疗失败率为13.6%(31/228),未接受者为21.7%(5/23),差异无统计学意义(P=0.29)。
- 闭塞型视网膜血管炎患者接受抗结核治疗后失败较少,但生存分析未达统计学显著(P=0.09)。
- 西班牙裔和非裔美国患者以及全葡萄膜炎相关结核性视网膜血管炎(相较于后葡萄膜炎)患者接受抗结核治疗后失败率更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未接受抗结核治疗的患者极少,无法就抗结核治疗的作用作出确定性结论。
- 本研究为回顾性研究,随访仅限1年,抗结核治疗的效应在随访期间可能被高估或低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Tubercular retinal vasculitis (TRV) is a heterogeneous disease that can be difficult to manage because of nonspecific presentation and limitations of confirmatory tests for tuberculosis. This is a big data analysis on phenotypes and treatment outcomes for TRV. METHODS: Multicentre retrospective study of patients with TRV between January 2004 and December 2014 and a minimum follow-up of 1 year. RESULTS: Two hundred and fifty-one patients with TRV with a mean age of 38.9 ± 14.4 years (range, 9-86 years) were included. The patients were predominantly males (n = 167/251; 66.5%) of Asian ethnicity (n = 174/246; 70.7%), and geographical origin (n = 137/251; 54.6%). Most patients had features of occlusive type of RV (n = 113/185; 61.1%) except Caucasians (n = 11; 28.2%). There was no significant difference in treatment failure whether patients received antitubercular therapy (ATT) (P = 0.29), although treatment failure was less frequent in patients who received ATT (13.6%; n = 31/228) compared with those who did not (21.7%, n = 5/23). Less treatment failures were observed in patients with occlusive type RV who received ATT; however, this was not significant on survival analysis (P = 0.09). Treatment with ATT was associated with higher failure rates in patients of Hispanic and African American race and those with TRV associated with panuveitis (compared with posterior uveitis). CONCLUSION: In this multinational study of TRV, there was no significant therapeutic effect of ATT. However, a definitive conclusion about the role of ATT could not be made because of a few patients who did not receive ATT. Because this is a retrospective study with a limited 1-year follow-up, the effect of ATT may have been overestimated (or underestimated) in the duration of follow-up.
引用
- Gunasekeran DV, Agrawal R, Agarwal A, et al. THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: A Multinational Review of 251 Patients With Tubercular Retinal Vasculitis. Retina. 2019. PMID: 29697588. doi:10.1097/IAE.0000000000002194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。